Company intelligence / Profile preview

Yield Capital

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Yield Capital (丰收资本) is a venture capital firm based in China that specializes in investments within the healthcare and technology sectors. The firm focuses on early to growth-stage companies, particularly those involved in biotechnology, medical devices, and digital health. Yield Capital has built a significant portfolio by backing innovative Chinese life science companies, including Abbisko Therapeutics and InventisBio. The firm aims to support the development of cutting-edge medical solutions and the growth of the healthcare ecosystem in the Asia-Pacific region.

Industry: Investors

Beyond the preview

Go deeper on Yield Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yield Capital.

Explore the full profile